(Q41667549)

6 October 2017

1 reference

title

Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? (English)

1 reference

6 October 2017

Schena FP

1

1 reference

6 October 2017

Gesualdo L

series ordinal

2

1 reference

6 October 2017

Grandaliano G

series ordinal

3

1 reference

6 October 2017

Montinaro V

series ordinal

4

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

52

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

1439-1457

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.475

6 October 2017

exact match

0 references

cites work

Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

End-stage renal disease in China

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Diversity of cytokine synthesis and function of mouse CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Development of Th 1- or Th 2-dominated immune responses: what about the polarizing signals?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Neutralizing inflammatory cytokines in nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

The detection of monocytes in human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Secretory products of macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Physiology of the mesangial cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Growth factors in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1997.475

1 reference

7 January 2021

Autocrine secretion and the physiological concentration of cytokines

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cytokines in T-cell development

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interleukin-6: an autocrine regulator of mesangial cell growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Three-dimensional structures of alpha and beta chemokines.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of re

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

LDL stimulates mesangial fibronectin production and chemoattractant expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Endothelin stimulates PDGF secretion in cultured human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Recent developments in the cell biology of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Epidermal growth factor and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Nephrotic syndrome due to primary renal disease in adults: I. Survey of incidence in South-east England.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Minimal change nephrosis and allergy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Detection of glomerular anionic sites in post-embedded ultra-thin sections using cationic colloidal gold.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cationic Colloidal Gold - A Novel Marker for the Demonstration of Glomerular Polyanion Status in Routine Renal Biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Changes in heparan sulfate correlate with increased glomerular permeability

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A glomerular permeability factor produced by human T cell hybridomas

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Pattern of interleukins in minimal-change nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

IL-8 production by peripheral blood mononuclear cells in nephrotic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

IL-1-like production in adriamycin-induced nephrotic syndrome in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Nephrotic syndrome associated with recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

The many masks of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Mechanisms of proteinuria in noninflammatory glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Recurrent focal glomerulosclerosis: natural history and response to therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

C5b-9 increases albumin permeability of isolated glomeruli in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Passive transfer of Heymann nephritis with serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Hepatitis C virus infection and membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Elevated urinary excretion of the C5b-9 complex in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Induction of Mediator Release from Human Glomerular Mesangial Cells by the Terminal Complement Components C5b-9

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Membranoproliferative glomerulonephritis and hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Secondary membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Intraglomerular immune cell infiltration and complement 3 deposits in membranoproliferative glomerulonephritis type I: a serial-biopsy study of 25 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A retrospective analysis of the natural history of primary IgA nephropathy worldwide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Actions of platelet-derived growth factor isoforms in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interleukin-4 expression in mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Detection of urinary interleukin-8 in glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Glomerulosclerosis: intrinsic and extrinsic pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Increased synthesis of extracellular matrix in mesangial proliferative nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Proteinases and glomerular matrix turnover

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A reappraisal of immune-mediated glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Lipid-induced glomerular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Tubulointerstitial changes as a major determinant in the progression of renal damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Understanding the nature of renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Leukocyte analysis using monoclonal antibodies in human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

New intracellular targets for therapeutic drug design

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Captopril inhibits the agonist-induced increase of cytosolic free Ca2+ in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1997.475

1 reference

7 January 2021

Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Reason for optimism over vascular gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

The state of the art in antisense research

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

IL-12 at the crossroads

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Modulation of antibody-mediated glomerular injury in vivo by interleukin-6

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Oral cytokine administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

HIV blocked by chemokine antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Ciprofloxacin enhances T cell function by modulating interleukin activities

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Converting enzyme inhibition in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Heparins for proliferative nephritides? Short review on an advancing topic

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.475

7 January 2021

Identifiers

DOI

10.1038/KI.1997.475

1 reference

release_6tcsmzarwnenxkammg6rmnq5bm

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6tcsmzarwnenxkammg6rmnq5bm

24 November 2022

mapped directly with Wikidata item

1 reference